The recently concluded visit to India by Boris Johnson, Prime Minister of the United Kingdom, saw Indian drugmakers and healthcare providers queuing to explore greater opportunities in the UK.
Among the biggest was generics supplier Accord Healthcare, a branch of Ahmedabad-based Intas Pharmaceuticals Limited, which is planning expansions in the UK. Binish Chudgar, Vice President and Managing Director of Accord Healthcare, met with the British Prime Minister and briefed him on expansion plans, Intas Pharmaceuticals informed in a social media post on LinkedIn.
Intas Pharmaceuticals would also seek to build strength in biosimilars in European markets with its strong base in the UK. Accord Healthcare operates in the UK with over 1,200 employees. It claims to be the largest pharmaceutical supplier in the UK with 15% of all medicines supplied by Accord.
In New Delhi, the CEO of the Covid-19 vaccine maker Serum Institute of India (SII), Adar Poonawalla, met Johnson at the residence of the British High Commission on April 22. After meeting, Poonawalla took to Twitter to express her gratitude.
Notably, in October last year, after interventions by Indian authorities, the UK government removed the mandatory 10-day quarantine and RT-PCR testing requirements for Indian travelers fully vaccinated with SII’s Covishield. Poonawalla was quick to thank Indian Prime Minister Narendra Modi and his British counterpart for the move.
Among health service providers, representatives of Kusum Dhirajlal Hospital Ahmedabad, a multi-specialty charity hospital, as well as British multinational medical equipment manufacturer, Smith & Nephew Plc, met with Johnson in Ahmedabad to showcase the capabilities of the hospital in robotic surgery and held discussions on the possible future. technological connections.
Separately, an investment announcement has come from Mumbai-based Jupiter Lifeline Hospitals Limited to set up a state-of-the-art neurorehabilitation center with 100 inpatient beds in the UK for stroke patients. strokes, traumatic brain injuries and neurological disorders, among others.
It will create more than 500 jobs in the UK, said Ankit Thakker, executive director and CEO of Jupiter Hospitals. “We look forward to working closely with the UK’s National Health Service (NHS) to make this available to the whole community, not just restricting it to the elites,” Thakker said.
Notably, there was the commitment of over £1bn of new investment and export deals, while it was not exactly clear how much was attributable to healthcare and pharmaceuticals, some significant ones included Gogji MedTech Startup’s investment of £10m to expand into the UK, creating 100 high-quality jobs, Brinton Pharmaceuticals committed to establishing a global research and development hub in UK with an investment of £30 million, creating around 300 jobs.
Microlabs, an Indian pharmaceutical company, has committed a £10 million investment to expand into the UK, in addition to Qure AI Technologies’ £6 million investment.
April 24, 2022